Introduction
============

Critically ill patients often receive red blood cell (RBC) transfusions. Studies conducted in Europe and the United States have reported that RBC transfusions were administered to approximately 40% of all patients \[[@B1],[@B2]\], with an average of almost 5 units of RBCs per patient; this has changed little over the past decade \[[@B3]\]. Some 40 to 80% of RBC transfusions in the intensive care unit (ICU) are not administered for hemorrhage, but for low hemoglobin levels, for a decrease in physiological reserve, or for alterations in tissue perfusion \[[@B2]\].

Few clinical techniques can directly monitor tissue oxygen levels or quantify tissue oxygen consumption (VO~2~). The presence of tissue hypoxia and how much transfusion is necessary to correct the oxygen deficit are therefore still hard to determine. It is even difficult to say whether RBC transfusion really improves tissue oxygenation. In pathological inflammatory conditions, such as sepsis or during the postoperative period, systemic oxygenation variables do not necessarily reflect local tissue oxygenation because of mechanisms such as shunting or vascular dysregulation \[[@B4]\]. Clinical studies on the efficacy of RBC transfusion have used different endpoints for tissue oxygenation, including systemic VO~2~, blood lactate, and base excess levels \[[@B5],[@B6]\]. A few studies have demonstrated an improvement in tissue oxygenation after RBC transfusion associated with an increase in oxygen delivery (DO~2~); other studies have not \[[@B7],[@B8]\]. More general and indirect survival measures, such as mortality, morbidity, or length of hospital stay \[[@B1],[@B9]-[@B11]\], are prone to confounding and are difficult to influence \[[@B9]\].

Near-infrared spectroscopy (NIRS) has recently emerged as a valuable tool for monitoring peripheral oxygenation in various tissues, including the muscle. By performing a vaso-occlusive test, a variety of NIRS-derived variables can be measured to assess, in particular, tissue VO~2~and micro-vascular reactivity \[[@B12]\].

The aim of the present study was to evaluate the effects of RBC transfusions on muscle tissue oxygenation, VO~2~and microvascular reactivity in critically ill patients using the NIRS technology.

Materials and methods
=====================

After approval by the ethical committee of Erasme Hospital, informed consent was obtained from each patient\'s next of kin. This prospective study enrolled consecutive patients hospitalized in the 31-bed Department of Intensive Care Medicine of Erasme Hospital with anemia requiring RBC transfusion. The indication for RBC transfusion was a hemoglobin concentration either \<8 g/dl or between 8 and 9 g/dl in the presence of altered tissue perfusion (that is, elevated lactate levels) or coronary artery syndromes. Exclusion criteria were RBC transfusion in the preceding 72 hours, peripheral vascular disease, liver cirrhosis, age \<18 years, active bleeding, and pregnancy. Hemodynamic and NIRS-derived variables were obtained immediately before (baseline) and 1 hour after transfusion of 1 unit packed RBCs. During the study period, no bedside procedures were performed, doses of vasopressor and sedative agents were kept constant, and the patient\'s position was not changed.

Red blood cell transfusion characteristics
------------------------------------------

Packed RBC units were obtained from the blood bank of Erasme Hospital, and were supplied by the Belgian Red Cross. All RBC units transfused in ICU patients in our hospital have undergone leukoreduction by filtration before storage in a saline-adenine-glucose-mannitol solution. The storage period can be extended up to 42 days, and there is no blood bank policy to preferentially transfuse fresh RBCs.

Measurements
------------

The temperature, heart rate, arterial pressure, and central venous pressure were recorded in all patients before and 1 hour after transfusion. In addition, complete hemodynamic measurements were obtained in 14 patients who were monitored with a pulmonary artery catheter. Arterial and central venous or mixed venous blood samples were withdrawn simultaneously, and blood gases, hemoglobin saturation, and hemoglobin and lactate concentrations were measured before and 1 hour after transfusion (ABL700; Radiometer, Copenhagen, Denmark). The DO~2~, VO~2~and oxygen extraction ratio were calculated using standard formulas \[[@B13]\]. The Acute Physiology and Chronic Health Evaluation II score \[[@B14]\] was obtained at admission, and the Sequential Organ Failure Assessment score \[[@B15]\] was obtained on the study day. The length of RBC storage before transfusion was noted in each case.

NIRS measurements and analysis
------------------------------

The thenar tissue oxygen saturation (StO~2~) and the tissue hemoglobin index (THI), an indicator of the blood volume in the region of the microvasculature sensed by the NIRS probe \[[@B16],[@B17]\], were measured using a tissue spectrometer (InSpectra™ Model 325; Hutchinson Technology Inc., Hutchinson, MN, USA), which uses reflectance mode probes to measure scattered light reflected at some distance from where the light is transmitted into the tissue. The maximum depth of the tissue sample was estimated as one-half of the distance between the probe\'s sending and receiving fibers (probe spacing); we used a probe spacing of 25 mm. A light-scattering calibrator was used to normalize the tissue spectrometer during startup of the system and before each measurement. Sample measurement signals were updated every 3.5 seconds.

When the patient was hemodynamically stable (mean arterial pressure \>65 mmHg and no change in vasopressor doses for 2 hours), the NIRS probe was placed on the skin of the thenar eminence and a sphygmomanometer cuff was wrapped around the arm over the brachial artery. After a 3-minute period necessary to stabilize the StO~2~signal, arterial inflow was stopped by inflation of the cuff to 50 mmHg above the systolic arterial pressure. After 3 minutes of ischemia the cuff pressure was released, and StO~2~was continuously recorded for another 3 minutes (reperfusion period). We measured the StO~2~and THI continuously during the vaso-occlusive test, and recorded the baseline StO~2~and THI before the ischemic period and the THI after 1 minute of occlusion. During occlusion, we calculated the StO~2~desaturation slope (%/minute) obtained by the regression line of the first minute of StO~2~decay after occlusion \[[@B16]\]. During the reperfusion phase, we calculated the StO~2~upslope of the reperfusion phase (%/second) obtained by the regression line of the first 14 seconds of increased StO~2~(five StO~2~values) following the ischemic period. This StO~2~upslope of the reperfusion phase was used to quantify the intensity of the reactive hyperemic response following release of the occluding cuff. The ΔStO~2~upslope of the reperfusion phase was calculated as the difference between the StO~2~upslopes of the reperfusion phase after and before transfusion. Muscle oxygen consumption (NIR VO~2~) was calculated as the product of the inverse value of the StO~2~desaturation slope and the mean THI over the first minute of arterial occlusion \[[@B16]\], and is expressed in arbitrary units:

ΔNIRVO~2~(arbitrary units) was calculated as the difference between the NIR VO~2~values after and before transfusion.

Statistical analysis
====================

Descriptive statistics were computed for all study variables. The Kolmogorov-Smirnov test was used to verify the normality of distribution of continuous variables. Wilcoxon\'s test was used to compare the baseline and post-transfusion values. The relationship between NIRS-derived variables was assessed by Spearman rank correlation. Data were analyzed using SPSS 12.0 for Windows (SPSS, Chicago, IL, USA). The level of statistical significance was 0.05. Data are presented as the median (25th to 75th percentiles).

Results
=======

The study included 44 hemodynamically stable patients, 18 of whom had sepsis (Table [1](#T1){ref-type="table"}). The median ICU length of stay was 10 (5 to 28) days, and the 28-day mortality was 27% (Table [1](#T1){ref-type="table"}). No transfusion-related adverse reaction was observed during the study. Blood transfusion resulted in increases in hemoglobin concentration (from 7.1 (6.7 to 7.7) to 8.4 (7.1 to 9) g/dl; *P*\< 0.01) and in DO~2~(from 306 (259 to 337) to 356 (332 to 422) ml/minute/m^2^; *P*\< 0.001). The mean arterial pressure also increased (from 76 (70 to 83) to 80 (74 to 93) mmHg; *P*\< 0.01) (Table [2](#T2){ref-type="table"}). Systemic VO~2~and NIRS-derived variables, however, were unaltered by transfusion (Table [2](#T2){ref-type="table"}).

###### 

Characteristics of the study group (n = 44 patients)

  --------------------------------------------------------- ---------------
  Age (years)                                               65 (57 to 73)
  Gender, male                                              29 (66)
  Body mass index                                           26 (23 to 27)
  Acute Physiology and Chronic Health Evaluation II score   15 (11 to 18)
  Sequential Organ Failure Assessment score                 6 (4 to 8)
  Medical diagnosis                                         24 (54.5)
  Sepsis                                                    18 (40.9)
  Intensive care unit length of stay (days)                 10 (5 to 28)
  Outcome, intensive care unit death                        12 (27.3)
  Vasopressor support                                       17 (38.6)
  Sedative agents                                           15 (34.1)
  Renal replacement therapy                                 6 (13.6)
  Red blood cell storage time (days)                        18 (11 to 27)
  --------------------------------------------------------- ---------------

Data are presented as median (25th to 75th percentiles) or *n*(%).

###### 

Physiologic and near-infrared spectroscopy-derived variables before and 1 hour after red blood cell transfusion

  Variable                                                                      Baseline              After transfusion
  ----------------------------------------------------------------------------- --------------------- --------------------
  Temperature (°C)                                                              36.8 (36.2 to 37.5)   37 (36.4 to 37.7)
  Heart rate (beats/minute)                                                     94 (78 to 114)        94 (77 to 115)
  Mean arterial pressure (mmHg)                                                 76 (70 to 83)         80 (74 to 93)\*
  Central venous pressure (mmHg)                                                12 (9 to 16)          12 (9 to 16)
  Mean pulmonary artery pressure (mmHg)^a^                                      29 (27 to 33)         30 (26 to 39)
  Pulmonary artery occlusion pressure (mmHg)^a^                                 17 (15 to 18)         19 (14 to 19)
  Cardiac index (l/minute/m^2^)^a^                                              3.0 (2.7 to 3.4)      3.1 (2.9 to 3.4)
  Hemoglobin concentration (g/dl)                                               7.1 (6.7 to 7.7)      8.4 (7.1 to 9)\*
  Arterial partial pressure of carbon dioxide (mmHg)                            35 (32 to 37)         35 (31 to 38)
  Arterial partial pressure of oxygen (mmHg)                                    94 (85 to 109)        93 (84 to 113)
  pH                                                                            7.45 (7.39 to 7.48)   7.44 (7.4 to 7.5)
  SaO~2~(%)                                                                     99 (98 to 99)         99 (98 to 99)
  Lactate (mmol/l)                                                              1.2 (0.9 to 2.2)      1.3 (0.8 to 2.1)
  Mixed venous oxygen saturation (%)^a^                                         65 (51 to 72)         70 (52 to 74)
  Oxygen delivery (ml/minute/m^2^)^a^                                           306 (259 to 337)      356 (332 to 422)\*
  Oxygen consumption (ml/minute/m^2^)^a^                                        116 (85 to 142)       118 (97 to 168)
  Oxygen extraction ratio (%)^a^                                                34 (28 to 48)         28 (24 to 46)
  Thenar tissue oxygen saturation (%)                                           90 (81 to 94)         90 (80 to 94)
  Tissue hemoglobin index (arbitrary units)                                     14 (13 to 17)         13 (11 to 18)
  Inverse thenar tissue oxygen desaturation slope (%/minute)                    22 (17 to 35)         21 (16 to 32)
  Thenar tissue oxygen saturation upslope of the reperfusion phase (%/second)   4.1 (2.1 to 5.4)      3.8 (2.9 to 5.1)
  Muscle oxygen consumption (arbitrary units)                                   363 (240 to 536)      373 (215 to 500)

Data are presented as median (25th to 75th percentiles). ^a^Measurements obtained in 14 patients equipped with a pulmonary artery catheter. \**P*\< 0.05 versus baseline.

Although RBC transfusion globally failed to affect NIRS-derived variables (Table [2](#T2){ref-type="table"}), there was considerable inter-individual variation, with improvement in some patients and deterioration in others. The ΔStO~2~upslope of the reperfusion phase was negatively correlated to the baseline StO~2~upslope of the reperfusion phase (*r*^2^= 0.42; *P*\< 0.0001) (Figure [1](#F1){ref-type="fig"}). This negative correlation was present in septic patients (*r*^2^= 0.46; *P*= 0.0044) and in nonseptic patients (*r*^2^= 0.41; *P*= 0.0027). ΔNIR VO~2~was also negatively correlated to baseline NIR VO~2~(*r*^2^= 0.48; *P*= 0.0015) (Figure [2](#F2){ref-type="fig"}). This latter correlation was present in septic patients (*r*^2^= 0.56; *P*\< 0.018) and in nonseptic patients (*r*^2^= 0.32; *P*= 0.04). ΔNIR VO~2~was weakly but significantly related to the ΔStO~2~upslope of the reperfusion phase (*r*^2^= 0.14; *P*= 0.038). There was no correlation between baseline physiologic variables or RBC storage time and the ΔStO~2~upslope of the reperfusion phase slope or ΔNIR VO~2~.

![**Relationship between baseline and change in thenar tissue oxygen saturation reperfusion phase upslopes**. *x*axis: Baseline thenar tissue oxygen saturation (StO~2~) upslope of the reperfusion phase (%/second); *y*axis: the difference between the StO~2~upslopes of the reperfusion phase after and before transfusion (%/second). *r*^2^= 0.42; *P*\< 0.0001.](cc8009-1){#F1}

![**Relationship between baseline muscle oxygen consumption and change in muscle oxygen consumption**. *x*axis: baseline muscle oxygen consumption (NIR VO~2~; arbitrary units); *y*axis: difference in NIR VO~2~after and before transfusion (ΔNIR VO~2~; arbitrary units). NIR VO~2~was calculated as the product of the inverse value of the thenar tissue oxygen saturation (StO~2~) desaturation slope and the mean tissue hemoglobin index over the first minute of arterial occlusion. *r*^2^= 0.48; *P*= 0.0015.](cc8009-2){#F2}

Discussion
==========

The main finding of our study was that RBC transfusion had no consistent effect on muscle StO~2~, VO~2~, or microvascular reactivity in critically ill patients. There was, however, considerable interindividual variability. Importantly, there was a divergent response, with an improvement in microvascular reactivity in patients with altered microvascular reactivity at baseline and a deterioration in microvascular reactivity in patients with preserved baseline microvascular reactivity. The same effect was observed for NIR VO~2~. The changes in NIRS derived-variables were not related to the RBC storage time.

The effects of blood transfusions on the microcirculation and tissue oxygenation are still poorly defined, especially in critically ill patients. Sakr and colleagues \[[@B18]\] studied the effects of RBC transfusion on the sublingual microcirculation assessed by the orthogonal polarization spectral technique in patients with severe sepsis. As in the present study, the authors reported that RBC transfusion had no consistent effect on sublingual microvascular perfusion in these septic patients \[[@B18]\]. There was again considerable interindividual variability in the response to RBC transfusions, with an improvement in sublingual microvascular perfusion in patients with altered perfusion at baseline and a deterioration in sublingual microvascular perfusion in patients with preserved baseline perfusion; these data are highly consistent with our results.

The critical question is why some patients show beneficial effects of RBC transfusions while others do not. Oxygenation of the microcirculation is the result of a close interplay between RBCs and microcirculatory vessels. If transfusion does not improve tissue oxygenation, this could be related to the condition of the microcirculation in the patient or to the RBCs. Endogenous RBC deformability may be an important factor. Indeed, RBC rheology is altered in various diseases, including acute conditions - such as ICU patients with sepsis or with an inflammatory reaction due to postoperative states or intracerebral hemorrhage - or chronic conditions - such as diabetes mellitus or terminal renal failure \[[@B19]\]. Friedlander and colleagues \[[@B20]\] observed that RBC transfusions improved RBC deformability in patients with sepsis, probably by replacing rigid, endogenous RBCs by more functional, or less dysfunctional, exogenous RBCs.

RBC storage may also be an important factor in determining individual response to transfusion. Alterations in RBCs during storage include a reduction in RBC deformability \[[@B21]\], altered adhesiveness and aggregability, and a reduction in 2,3-diphosphoglycerate and ATP levels \[[@B22]\]. These findings were challenged by Raat and colleagues \[[@B23]\], however, who reported that storage of rat RBCs for up to 5 weeks did not alter their deformability or their oxygen-carrying properties. A recent literature review reported no strong association between duration of storage and complications \[[@B24]\]. A small clinical study suggested an adverse effect of RBC storage on intramucosal pH \[[@B5]\], but other studies failed to confirm these findings \[[@B6],[@B25]\]. In a prospective, observational trial in patients with severe traumatic brain injury \[[@B26]\], transfusion of RBCs increased cerebral oxygenation, except in patients transfused with RBCs that had been stored for more than 19 days. The median RBC storage time in our study was 18 days, as in other studies \[[@B2],[@B27]\], and there was no relationship between the changes in NIRS-derived variables after transfusion and RBC storage time.

Reactive hyperemia can be considered an integral test of microcirculatory reactivity \[[@B28]\], evaluating the tissue\'s ability to adjust oxygen extraction capabilities to DO~2~after a hypoxic stimulus induced by a transient interruption of blood flow. This process is complex, involving capillaries, arterioles, and small arteries, increasing flow in previously patent capillaries and recruiting additional capillaries. Hypoxic stimuli induce dilation of precapillary arterioles, favoring the opening of closed capillaries (recruitment) and increasing blood flow in previously patent capillaries - a phenomenon called reactive hyperemia. Alterations in the microcirculation have been reported in patients with sepsis \[[@B29]\] and in patients with inflammatory reactions due to postoperative states or other diseases \[[@B30],[@B31]\]. These alterations are typically characterized by a decrease in microvascular density and an increase in the heterogeneity of microvascular blood flow, with an increase in intermittent or stopped flow capillaries, which could limit the number of recruitable capillaries after a hypoxic stimulus and thus alter the reactive hyperemia phenomenon \[[@B32]\].

The mechanisms that control the microvascular distribution of capillary blood flow under hypoxic conditions are not completely understood. The endothelium seems to play a central role both as an oxygen sensor \[[@B33]\] and by inducing vasodilatation \[[@B34]\] by releasing nitric oxide \[[@B33],[@B35],[@B36]\]. The K~ATP~channels in the vascular smooth muscle also play a significant role in matching oxygen supply to demand during ischemia \[[@B37]\]. In addition to their role as microcirculatory components, RBCs are now considered primordial actors in the delivery of oxygen, rather than just being oxygen transporters. Indeed, RBCs can use hemoglobin not only as an oxygen carrier but also as an oxygen sensor, which can modulate tissue oxygen flow variables - by the release of the vasodilators, nitric oxide \[[@B38],[@B39]\] or ATP \[[@B40]\]. This release of vasodilators from RBCs during hypoxia could be impaired during storage. The transfusion of stored RBCs could therefore affect microvascular reactivity to hypoxia in patients who have preserved microvascular reactivity before transfusion.

Transfusions may therefore be deleterious when performed in patients with preserved deformability and/or vasoreactivity but may be favorable when performed in patients with markedly altered RBC deformability and/or vasoreactivity. These findings may explain why RBC transfusion decreased microvascular reactivity and NIR VO~2~when these were essentially normal at baseline but improved these variables when they were already decreased at baseline. Interestingly, RBC transfusion-induced changes in the StO~2~upslope of the reperfusion phase were related to changes in NIR VO~2~, suggesting that an improvement in microvascular reactivity (and perhaps an improvement in microvascular blood flow) is associated with an increase in local muscle VO~2~.

Although there was considerable interindividual variability, globally StO~2~was not altered by RBC transfusion. There was no relationship between baseline StO~2~and the change in StO~2~after RBC transfusion. Nevertheless, the present study was performed in hemodynamically stable patients, sometimes several days after their ICU admission. Baseline StO~2~values were also in the normal range \[[@B41]\]. RBC transfusion may have different effects on StO~2~if given in the early phase of resuscitation.

The THI was not altered by RBC transfusion. It is well known that hematocrit is lower in the capillaries than in large arteries and veins as a result of heterogeneous flow distribution, the Fahraeus effect, and interactions between a luminal glycocalyx and plasma macromolecules \[[@B42]-[@B44]\]. In this context, increasing the systemic hematocrit by RBC transfusion has only limited effects on the microvascular hematocrit. Using NIRS technology, Doerschug and colleagues showed that the THI was not related to blood hemoglobin concentration in patients with severe sepsis \[[@B45]\].

Our study has some limitations. First, the NIRS technology itself has some limitations. StO~2~represents the average of the hemoglobin oxygen saturation in arterioles, venules, and capillaries in the measured volume of tissue, and the relative contributions of arterial, venous, and capillary blood within the measured volume of tissue cannot be determined. NIRS does not measure microcirculatory blood flow, and therefore the increase in StO~2~after temporary arterial occlusion does not necessarily reflect the local increase in DO~2~characterizing the reactive hyperemic response. Furthermore, measurements are influenced by adipose tissue thickness \[[@B46]\] - the thenar eminence is therefore usually selected for NIRS studies because the thickness of the adipose tissue covering this muscle is less influenced by the body mass index. Second, our measurements were restricted to 1 hour after RBC transfusion, so we may have missed alterations that occurred later. Our study already lasted for a total of about 2 hours (including the time needed for RBC transfusion), however, and longer follow-up periods are practically difficult because of inevitable changes in therapy and procedures. In addition, spontaneous changes in the patient\'s condition may influence microcirculatory perfusion and tissue oxygenation. Nevertheless, changes in the microcirculation are expected to occur early after the RBC transfusion, so it is unlikely that extending the study period would have altered our conclusions.

Conclusion
==========

The effects of RBC transfusions on muscle oxygenation and microvascular reactivity are quite variable and are dependent on some baseline NIRS-derived variables. These effects cannot be predicted from systemic hemodynamics, biological variables, or disease severity, and are also independent of the age of the transfused RBCs. Although further studies are needed, the NIRS technique may represent a valuable tool to help evaluate the effects of RBC transfusions in acutely ill patients.
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